BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 6540110)

  • 1. Pharmacokinetics and the antiarrhythmic effect of mexiletine in patients with chronic ventricular arrhythmias.
    Ohashi K; Ebihara A; Hashimoto T; Hosoda S; Kondo K; Oka T
    Arzneimittelforschung; 1984; 34(4):503-7. PubMed ID: 6540110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anti-arrhythmic efficacy of the amiodarone-mexiletine combination in the treatment of resistant complex ventricular arrhythmias].
    Purcaro A; Massacci C; Curzi G; Pigini G; Costantini C; Bilancini A; Blandini A
    G Ital Cardiol; 1986 May; 16(5):417-26. PubMed ID: 3732727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mexiletine in treatment of chronic ventricular refractary arrhythmias (author's transl)].
    Bellocci F; Ansalone G; Scabbia E; Santarelli P; Lucente M; Affinito V; Loperfido F; Zecchi P
    G Ital Cardiol; 1981; 11(4):488-97. PubMed ID: 6169580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mexiletine in the treatment of ventricular arrhythmias.
    Henrard L; Carlier J
    Acta Cardiol Suppl; 1980; (25):127-35. PubMed ID: 6966452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of ventricular arrhythmias with mexiletine].
    Trenckmann H; Neugebauer A; Krosse B
    Z Gesamte Inn Med; 1982 May; 37(9):259-62. PubMed ID: 7048773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of mexiletine in renal insufficiency.
    Baudinet G; Henrard L; Quinaux N; El Allaf D; de Landsheere C; Carlier J; Dresse A
    Acta Cardiol Suppl; 1980; (25):55-65. PubMed ID: 6966453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the antiarrhythmic efficacy of mexiletine in patients with chronic ventricular arrhythmias.
    Van Durme JP
    Acta Cardiol Suppl; 1980; (25):121-5. PubMed ID: 6990664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mexiletine in the management of ventricular dysrhythmias.
    Campbell NP; Pantridge JF; Adgey AA
    Eur J Cardiol; 1977 Dec; 6(4):245-58. PubMed ID: 590296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anti-arrhythmic effects of mexiletine].
    Ledain L; Page A; Favreau L; Besse P
    Arch Mal Coeur Vaiss; 1982 May; 75(5):605-12. PubMed ID: 6180692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of intravenous mexiletine in patients with acute myocardial infarction.
    Pentikäinen PJ; Halinen MO; Helin MJ
    J Cardiovasc Pharmacol; 1984; 6(1):1-6. PubMed ID: 6199590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mexiletine in the treatment of ventricular arrhythmias (author's transl)].
    Schlemmer M; Wimmer M
    Padiatr Padol; 1982; 17(2):383-9. PubMed ID: 6179031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of mexiletine in ventricular arrhythmias among patients in Taiwan: assessment by 24-hour Holter electrocardiography.
    Hwang YS; Wang JL
    Clin Ther; 1989; 11(3):392-7. PubMed ID: 2743373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of mexiletine in chronic ventricular arrhythmias: a multicentre double-blind medium-term trial.
    Poggesi L; Scarti L; Ieri A; Lanzetta T; Grazzini M; Del Bene P; Masini G; Del Citerna F; Carnovali M; Masotti G
    Int J Clin Pharmacol Res; 1989; 9(4):269-75. PubMed ID: 2476406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical antiarrhythmic efficacy of mexiletine: a review.
    Kulbertus HE
    Acta Cardiol Suppl; 1980; (25):111-20. PubMed ID: 6990663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mexiletine therapy of ventricular extrasystoles in the acute phase of myocardial infarction].
    Juillard A; Bouajina A; Barrillon A; Gay J; Gerbaux A
    Ann Cardiol Angeiol (Paris); 1984; 33(2):117-20. PubMed ID: 6201121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative studies on the cardiodepressant effect of disopyramide, mexiletine and propafenon].
    Angermann C; Jahrmärker H
    Z Kardiol; 1983 Nov; 72(11):665-74. PubMed ID: 6659643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophysiological properties of mexiletine assessed with respect to plasma concentrations.
    Joseph SP; Holt DW
    Eur J Cardiol; 1980 Feb; 11(2):115-21. PubMed ID: 7363924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mexiletine for the treatment of ventricular arrhythmias associated with chronic obstructive pulmonary disease.
    Fracalossi C; Ziacchi V; Farisè F; Rossi A; Marino A; Lomanto B; Moretti L
    G Ital Cardiol; 1989 Jan; 19(1):46-52. PubMed ID: 2744314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Early interruption of antiarrhythmia treatment in the acute phase of infarction complicated by ventricular arrhythmia].
    Sebbah J; Khemache A; Gryman R; Farinotti R; Guérot C; Valère PE
    Ann Cardiol Angeiol (Paris); 1985 Mar; 34(3):129-32. PubMed ID: 4004087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absorption and antiarrhythmic efficacy of sustained-release mexiletine.
    Holt DW; Chadwick DE; Campbell RW
    Clin Ther; 1983; 5(3):268-78. PubMed ID: 6850720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.